Abdera Therapeutics Inc.

AB

The mark consists of stylized Greek letters alpha beta.;chemicals for pharmaceutical use, namely, for the treatment, prevention, or diagnosis of cancer; pharmaceutical drugs used for the treatment, prevention, or diagnosis of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products used for the treatment, prevention, and diagnosis of cancer; pharmaceutical products for use in relation to radiotherapy, namely, products to target and treat tumors and cancer; pharmaceutical preparations, namely, pharmaceuticals using alpha radiation therapies for the treatment of cancer; diagnostic imaging agents for use in diagnosing cancer;Color is not claimed as a feature of the mark.;providing medical and business information via a website;medical kits comprised of single and multi-dose vials and syringes to administer pharmaceutical products used for the treatment, prevention, and diagnosis of cancer;medical and scientific research in the field of cancer treatment and diagnosis, in particular, radiotherapy to target and treat tumors and cancer;